NIH-funded research NIH-funded research

How gut bacteria and a 'primed' colon may drive colon polyps

Official title: The gut microbiome, interactions with primed colon states, and effects on adenoma formation and progression

Funded at Fred Hutchinson Cancer Center · NIH-11412577 · Data updated 2026-11-12

This project looks at whether certain gut bacteria together with molecular changes in the colon make people more likely to develop colon polyps, especially for those at risk of colorectal cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 20, 2022
Project endAugust 31, 2027
Funding year2025
Award (this year)$255,000
NIH project number3U54CA274374-04S2
Project IDNIH-11412577 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are adults with a history of colorectal adenomas or people undergoing colonoscopy who can provide stool and tissue samples for analysis.

Less likely to help

People without colon conditions or who cannot provide the required biological samples are unlikely to receive direct benefit from participation.

What this research studies

From a patient's perspective, researchers will compare microbial DNA from people with different kinds of colon polyps and use special germ‑free (gnotobiotic) mice to see how those microbes affect polyp formation. They'll combine detailed metagenomic analysis with statistical methods to understand how a 'primed' colon (molecular changes that make the colon more vulnerable) and specific bacteria interact. The team will analyze samples from a unique human cohort to find microbial patterns linked to aggressive versus slow-growing adenomas. The long-term aim is to translate these findings into microbiome‑based prevention strategies to lower the risk of adenomas and colorectal cancer.

Why it matters

Potential benefit: If successful, this work could lead to new microbiome-based ways to prevent colon polyps and reduce colorectal cancer risk.

How similar studies have gone: Previous studies have linked gut bacteria to colon polyps, but turning those links into proven prevention strategies is still new and not yet established.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Dey, Neelendu — Fred Hutchinson Cancer Center
  • Study coordinator: Dey, Neelendu

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.